Skip to main content
Premium Trial:

Request an Annual Quote

FGT Secures $2M ATP Grant for Pharmacogenomics Database

NEW YORK, May 11 (GenomeWeb News) - The National Institute of Standards and Technology has awarded First Genetic Trust a $2 million Advanced Technology Program grant to develop a pharmacogenomics database, the company said today.


The two-year award will support development of an information system to manage medical and genetic data related to adverse drug reactions and pharmacogenomics. Specifically, the grant will fund a prototype "clearinghouse ... that will support large-scale surveillance and research studies into the genetic basis for adverse drug reactions," according to the project brief.


FGT said that the system will provide patients with a secure communication mechanism that will allow them to interact anonymously with researchers. Conversely, patients can be re-contacted by researchers to participate in research studies, while maintaining their anonymity.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.